Skip to main content
. 2015 Oct 15;5:15037. doi: 10.1038/srep15037

Table 2. Quantification of COX-I and NDUFB8 deficiency in two serial skeletal muscle sections from 5 patients.

Patients   COX-I NDUFB8
Pos Int(+) Int(−) Neg Pos Int(+) Int(−) Neg n
P1 (LRPPRC mutations) Day 1 0.2% 3.8% 15.3% 80.7% 99.8% 0.2% 0.0% 0.0% 424
Day 2 0.2% 4.5% 17.3% 78.0% 99.6% 0.3% 0.1% 0.0% 1258
E (D1–D2) 0.1% −0.8% −2.0% 2.7% 0.2% −0.1% −0.1%  
95% CI (D1–D2) −0.4%, 0.6% −2.9%, 1.4% −6.0%, 2.0% −1.7%, 7.1% −0.4%, 0.7% −0.6%, 0.5% −0.2%, 0.1%  
P2 (m.4175G > A MT-ND1) Day 1 99.9% 0.1% 0.0% 0.0% 9.6% 0.4% 0.2% 89.7% 823
Day 2 100.0% 0.0% 0.0% 0.0% 11.9% 0.3% 0.1% 87.8% 932
E (D1–D2) −0.1% 0.1% −2.3% 0.2% 0.1% 2.0%  
95% CI (D1–D2) −0.3%, 0.1% −0.1%, 0.3% −5.0%, 0.5% −0.4%, 0.7% −0.2%, 0.5% −0.8%, 4.8%  
P11(Multiple mtDNA deletions) Day 1 72.8% 5.3% 3.2% 18.7% 63.4% 12.4% 4.7% 19.6% 1589
Day 2 71.2% 5.2% 2.7% 21.0% 54.4% 19.0% 4.1% 22.5% 2400
E (D1–D2) 1.7% 0.1% 0.5% −2.3% 9.0% −6.6% 0.6% −2.9%  
95% CI (D1–D2) −1.2%, 4.5% −1.3%, 1.5% −0.6%, 1.6% −4.8%, 0.3% 5.9%, 12.1% −8.9%, −4.4% −0.7%, 1.9% −5.5%, 0.3%  
P17 (m.5690A>G MT-TN) Day 1 91.5% 1.0% 1.2% 6.2% 79.6% 7.1% 3.3% 10.0% 1362
Day 2 91.5% 1.1% 1.2% 6.2% 81.2% 5.9% 3.6% 9.3% 1512
E (D1–D2) 0.0% −0.1% 0.1% 0.0% −1.6% 1.2% −0.3% 0.7%  
95% CI (D1–D2) −2.0%, 2.1% −0.9%, −0.7% −0.8%, 0.9% −1.8%, 1.8% −4.5%, 1.3% −0.6%, 3.0% −1.6%, 1.1% −1.5%, 2.8%  
P18 (Novel MT-TP mutation) Day 1 0.5% 1.1% 2.5% 95.9% 0.4% 0.5% 4.4% 94.7% 1012
Day 2 0.4% 0.9% 1.6% 97.0% 0.2% 0.4% 2.2% 97.2% 1689
E (D1–D2) 0.1% 0.1% 0.9% −1.1% 0.2% 0.1% 2.3% −2.6%  
95% CI (D1–D2) −0.5%, 0.6% −0.7%, 0.9% −0.3%, 2.0% −2.6%, 0.4% −0.2%, 0.7% −0.5%, 0.6% 0.8%, 3.2% −4.1%, −1.0%  

Key: E (D1–D2) = estimate for difference between Day 1 and Day 2; 95% CI (D1-D2) = 95% confidence interval for the difference between Day 1 and Day 2; n = number of fibres quantified; Pos = positive, Int(+) = intermediate positive, Int(−) = intermediate negative, Neg = negative.